Clinical Trial Update: Efficacy of 20% Autologous Serum Drops in the Treatment of Corneal Epitheliopathy Associated With Antihypertensive Glaucoma Drops. [Phase 4]

View source ↗

Summary

Phase 4 trial assessing 20% autologous serum drops for corneal epitheliopathy associated with antihypertensive glaucoma drops; not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Disease
• Corneal Epitheliopathy
• Dry Eye
• Glaucoma

Drugs mentioned

• Autologous serum drops (20%)

Snippet

Sponsor: Université de Sherbrooke | Conditions: Corneal Epitheliopathy, Glaucoma | Phase 4 | Status: NOT_YET_RECRUITING